ResearcherShanghai Jiao Tong UniversityNo recent work listed
Xiaoping Li
Matched on ORCID iD 0000-0002-0603-0820; OpenAlex author ID A5100397108. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2015: 2 papers · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 5
- An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2021.103271↗
- Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis. Co-author DOI 10.1186/s12957-016-0792-x↗
- Retrospective analysis of high intensity focused ultrasound combined with S-1 in the treatment of metastatic pancreatic cancer after failure of gemcitabine. Co-author PMID 27073725↗
- Expression of CD44 in pancreatic cancer and its significance. Co-author PMID 26261555↗
- Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis. Co-author PMID 26722393↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Leizhen Zheng · 2 shared papers, 2015–2016 · strength 0.16
- Min Li · 1 shared paper, 2021 · strength 0.11
- Xiuhui Shi · 1 shared paper, 2021 · strength 0.11
- Zhijun Zhou · 1 shared paper, 2021 · strength 0.11
- Jingxuan Yang · 1 shared paper, 2021 · strength 0.11
- Mingyang Liu · 1 shared paper, 2021 · strength 0.11
- Courtney W. Houchen · 1 shared paper, 2021 · strength 0.11
- Lacey R. McNally · 1 shared paper, 2021 · strength 0.11
- Hanxiang Zhan · 1 shared paper, 2021 · strength 0.11
- Zheng Leizhen · 1 shared paper, 2016 · strength 0.08
- Hua Zhao · 1 shared paper, 2016 · strength 0.08
- Kun Wang · 1 shared paper, 2016 · strength 0.08
- Zhiqiang Meng · 1 shared paper, 2016 · strength 0.08
- Wei-Jian Guo · 1 shared paper, 2015 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.